This company listing is no longer active
DFMA Stock Overview
Operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator in California and Colombia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Pideka Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.011 |
| 52 Week High | US$0.098 |
| 52 Week Low | US$0.0005 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -88.21% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| DFMA | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | 0.2% |
| 1Y | -88.2% | -16.5% | 7.6% |
Return vs Industry: DFMA underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: DFMA underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| DFMA volatility | |
|---|---|
| DFMA Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: DFMA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DFMA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 48 | Borja Sanz De Madrid | www.iknkbrands.com |
Ikänik Farms, Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator in California and Colombia. The company offers pharmaceutical grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil for scientific and commercial sales. It provides its products under the Ikanik, Essentials, Ronen, and Rations brands.
Pideka Group Inc. Fundamentals Summary
| DFMA fundamental statistics | |
|---|---|
| Market cap | €5.55m |
| Earnings (TTM) | -€15.91m |
| Revenue (TTM) | €1.94m |
0.0x
P/S Ratio0.0x
P/E RatioIs DFMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DFMA income statement (TTM) | |
|---|---|
| Revenue | US$1.94m |
| Cost of Revenue | US$1.77m |
| Gross Profit | US$163.05k |
| Other Expenses | US$16.07m |
| Earnings | -US$15.91m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.071 |
| Gross Margin | 8.41% |
| Net Profit Margin | -821.01% |
| Debt/Equity Ratio | 29.4% |
How did DFMA perform over the long term?
See historical performance and comparison